Zhiyuan Ke

993 total citations
20 papers, 771 citations indexed

About

Zhiyuan Ke is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Zhiyuan Ke has authored 20 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Zhiyuan Ke's work include Wnt/β-catenin signaling in development and cancer (5 papers), Cancer-related gene regulation (5 papers) and Peptidase Inhibition and Analysis (4 papers). Zhiyuan Ke is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (5 papers), Cancer-related gene regulation (5 papers) and Peptidase Inhibition and Analysis (4 papers). Zhiyuan Ke collaborates with scholars based in Singapore, China and United States. Zhiyuan Ke's co-authors include Kedong Yin, May Ann Lee, David M. Virshup, Babita Madan, Vishal Pendharkar, Rami N. Hannoush, Kyle David Proffitt, Lijun Ding, Vladimir Korzh and Zhiyuan Gong and has published in prestigious journals such as Biomaterials, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhiyuan Ke

19 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiyuan Ke Singapore 12 457 139 114 61 59 20 771
Valeria Di Dato Italy 15 255 0.6× 81 0.6× 65 0.6× 20 0.3× 56 0.9× 23 649
Chen Zhong China 21 564 1.2× 94 0.7× 58 0.5× 68 1.1× 92 1.6× 39 1.4k
Stéphane Houel United States 18 745 1.6× 66 0.5× 77 0.7× 72 1.2× 129 2.2× 21 1.1k
Julie Kelly United States 15 288 0.6× 135 1.0× 163 1.4× 40 0.7× 36 0.6× 50 968
S Yoshizawa Japan 10 402 0.9× 94 0.7× 43 0.4× 81 1.3× 77 1.3× 17 749
Anthony Natoli Australia 14 484 1.1× 308 2.2× 35 0.3× 127 2.1× 173 2.9× 15 985
Seung Hyeon Kim South Korea 18 282 0.6× 53 0.4× 261 2.3× 44 0.7× 61 1.0× 65 961
Hao Luo China 13 377 0.8× 124 0.9× 133 1.2× 14 0.2× 114 1.9× 33 587
Eric P. Miller United Kingdom 20 507 1.1× 310 2.2× 52 0.5× 70 1.1× 150 2.5× 29 1.1k
Emilia Maneiro Spain 17 360 0.8× 41 0.3× 64 0.6× 63 1.0× 102 1.7× 32 1.1k

Countries citing papers authored by Zhiyuan Ke

Since Specialization
Citations

This map shows the geographic impact of Zhiyuan Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiyuan Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiyuan Ke more than expected).

Fields of papers citing papers by Zhiyuan Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiyuan Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiyuan Ke. The network helps show where Zhiyuan Ke may publish in the future.

Co-authorship network of co-authors of Zhiyuan Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiyuan Ke. A scholar is included among the top collaborators of Zhiyuan Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiyuan Ke. Zhiyuan Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ke, Zhiyuan, et al.. (2025). Beyond L2: Leveraging Sinkhorn Distance for Improved Resistivity Recovery in 3-D Magnetotelluric Inversion. IEEE Transactions on Geoscience and Remote Sensing. 64. 1–15.
2.
Huang, Qiwei, Weijun Xu, Elizabeth Yihui Ng, et al.. (2024). Identification of small‐molecule binding sites of a ubiquitin‐conjugating enzyme‐UBE2T through fragment‐based screening. Protein Science. 33(3). e4904–e4904. 6 indexed citations
3.
Ke, Zhiyuan, Sifang Wang, Jayantha Gunaratne, et al.. (2024). Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D‐Cys6‐LHRH vedotin, against ovarian cancer cell lines. Chemical Biology & Drug Design. 103(4). e14516–e14516. 3 indexed citations
4.
Wang, Sifang, Qiwei Huang, Xiaoying Koh, et al.. (2023). Identification and characterization of inhibitors covalently modifying catalytic cysteine of UBE2T and blocking ubiquitin transfer. Biochemical and Biophysical Research Communications. 689. 149238–149238. 2 indexed citations
5.
Huang, Qiwei, et al.. (2023). Backbone 1H, 15N and 13C resonance assignments for an E2 ubiquitin conjugating enzyme-UBE2T. Biomolecular NMR Assignments. 17(2). 269–274. 3 indexed citations
6.
Ho, Soo Yei, Jenefer Alam, Duraiswamy A. Jeyaraj, et al.. (2017). Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors. Journal of Medicinal Chemistry. 60(15). 6678–6692. 26 indexed citations
7.
Madan, Babita, Zhiyuan Ke, Nathan Harmston, et al.. (2016). Abstract B13: ETC-159 is a novel PORCN inhibitor effective for treatment of Wnt-addicted genetically defined cancers. Molecular Cancer Research. 14(4_Supplement). B13–B13. 1 indexed citations
8.
Madan, Babita, Zhiyuan Ke, Masanobu Oshima, et al.. (2016). NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition. Oncotarget. 7(11). 12386–12392. 21 indexed citations
9.
Lee, May Ann, Babita Madan, Shi Hua Ang, et al.. (2015). Discovery and Optimization of a Porcupine Inhibitor. Journal of Medicinal Chemistry. 58(15). 5889–5899. 32 indexed citations
10.
Poulsen, Anders, Soo Yei Ho, Weiling Wang, et al.. (2015). Pharmacophore Model for Wnt/Porcupine Inhibitors and Its Use in Drug Design. Journal of Chemical Information and Modeling. 55(7). 1435–1448. 19 indexed citations
11.
Gopalan, Began, et al.. (2014). Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma. Biomaterials. 35(26). 7479–7487. 9 indexed citations
12.
Ke, Zhiyuan, Hongrui Liu, Saran Kumar, et al.. (2013). ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice. International Journal of Cancer. 133(2). 294–306. 34 indexed citations
13.
Proffitt, Kyle David, Babita Madan, Zhiyuan Ke, et al.. (2012). Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer. Cancer Research. 73(2). 502–507. 308 indexed citations
14.
Gopalan, Began, Zhiyuan Ke, Chunyan Zhang, et al.. (2011). Metal-free imidazolium salts inhibit the growth of hepatocellular carcinoma in a mouse model. Laboratory Investigation. 91(5). 744–751. 15 indexed citations
15.
Ding, Zhaobing, et al.. (2011). An orally available small imidazolium salt ameliorates inflammation and fibrosis in a murine model of cholestasis. Laboratory Investigation. 91(5). 752–763. 11 indexed citations
16.
Ho, Gideon, Saravana Kumar, Zhiyuan Ke, et al.. (2010). Imidazolium Salt (DBZIM) Reduces Gliosis in Mice Treated with Neurotoxicant 2′-CH3-MPTP. CNS Neuroscience & Therapeutics. 17(3). 148–157. 6 indexed citations
17.
Xiang, Wei, Zhiyuan Ke, Yong Zhang, et al.. (2009). Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice. Journal of Cellular and Molecular Medicine. 15(2). 359–374. 58 indexed citations
18.
Ke, Zhiyuan, et al.. (2007). Combined activity of the two Gli2 genes of zebrafish play a major role in Hedgehog signaling during zebrafish neurodevelopment. Molecular and Cellular Neuroscience. 37(2). 388–401. 37 indexed citations
19.
20.
Yin, Kedong, et al.. (2004). Temporal and spatial distribution of dissolved oxygen in the Pearl River Estuary and adjacent coastal waters. Continental Shelf Research. 24(16). 1935–1948. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Di Dato Breakdown of academic impact, for papers by Chen Zhong Breakdown of academic impact, for papers by Stéphane Houel Breakdown of academic impact, for papers by Julie Kelly Breakdown of academic impact, for papers by S Yoshizawa Breakdown of academic impact, for papers by Anthony Natoli Breakdown of academic impact, for papers by Seung Hyeon Kim Breakdown of academic impact, for papers by Hao Luo Breakdown of academic impact, for papers by Eric P. Miller Breakdown of academic impact, for papers by Emilia Maneiro
Rankless by CCL
2026